Abstract
Recently, mass spectrometric related techniques have been widely applied for the identification and quantification of neurochemicals and their metabolites in biofluids. This article presents an overview of mass spectrometric techniques applied in the detection of neurological substances and their metabolites from biological samples. In addition, the advances of chromatographic methods (LC, GC and CE) coupled with mass spectrometric techniques for analysis of neurochemicals in pharmaceutical and biological samples are also discussed.
Keywords: Neurochemicals, LC-MS, GC-MS, CE-MS, MALDI-MS.
Current Neuropharmacology
Title:Recent Advances in Mass Spectrometry for the Identification of Neurochemicals and their Metabolites in Biofluids
Volume: 11 Issue: 4
Author(s): Suresh Kumar Kailasa and Hui-Fen Wu
Affiliation:
Keywords: Neurochemicals, LC-MS, GC-MS, CE-MS, MALDI-MS.
Abstract: Recently, mass spectrometric related techniques have been widely applied for the identification and quantification of neurochemicals and their metabolites in biofluids. This article presents an overview of mass spectrometric techniques applied in the detection of neurological substances and their metabolites from biological samples. In addition, the advances of chromatographic methods (LC, GC and CE) coupled with mass spectrometric techniques for analysis of neurochemicals in pharmaceutical and biological samples are also discussed.
Export Options
About this article
Cite this article as:
Kailasa Kumar Suresh and Wu Hui-Fen, Recent Advances in Mass Spectrometry for the Identification of Neurochemicals and their Metabolites in Biofluids, Current Neuropharmacology 2013; 11 (4) . https://dx.doi.org/10.2174/1570159X11311040007
DOI https://dx.doi.org/10.2174/1570159X11311040007 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
Call for Papers in Thematic Issues
Advances in Neuroinflammation and Neuroprotection: Mechanisms and Therapeutic Frontiers
It offers a comprehensive exploration of neuroinflammatory and neuroprotective pathways that play central roles in a range of neurological disorders, including stroke, traumatic brain injury, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. This issue invites research on the cellular and molecular mechanisms driving neuroinflammation, such as the roles of ...read more
Advances in paediatric and adult brain cancers: emerging targets and treatments
Brain tumors are the most common solid tumors affecting children and adolescents, with up to 5,000 children diagnosed per year. Pediatric brain tumors, because of their location, are often untreatable and their clinical management can cause significant long-term impairment to intellectual and neurological function with epilepsy and neurodegeneration. Other than ...read more
Emotion (Dys)regulation: An integration of Pharmacological, Neurobiological, and Psychological Frameworks
Emotion regulation is a critical aspect of mental well-being and interpersonal relationships. To fully understand and effectively address emotion regulation, an integrative approach that considers pharmacological, neurobiological, and psychological frameworks is essential. Pharmacological interventions, such as medications targeting neurotransmitter imbalances, can play a significant role in managing emotional dysregulation. Understanding ...read more
Intercellular Communications in Cerebral Ischemia
Cerebral ischemia, a condition in which there is inadequate blood supply to the brain, ranks as one of the leading causes of disability and mortality globally. Despite its prevalence and severity, efficacious treatment options for this debilitating disorder remain limited. Recent scientific explorations have delved deeply into the pathological mechanisms ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanotechnology Advancements in the Diagnosis and Prevention of COVID-19: Past and Future
Coronaviruses Diagnosis and Treatment of Cyclothymia: The “Primacy” of Temperament
Current Neuropharmacology Peptide Prodrugs for the Treatment of CNS Disorders: A Perspective for New Drugs
Current Medicinal Chemistry Multiple Sclerosis: Risk Factors and their Interactions
CNS & Neurological Disorders - Drug Targets Patent Selections
Current Biomarkers (Discontinued) Predicting Stability of Mild Cognitive Impairment (MCI): Findings of a Community Based Sample
Current Alzheimer Research Role of Glioma-associated GLI1 Oncogene in Carcinogenesis and Cancertargeted Therapy
Current Cancer Drug Targets Defining Dystonic Tremor
Current Neuropharmacology Discovering New In Silico Tools for Antimicrobial Peptide Prediction
Current Drug Targets APP Transgenic Mouse Models and their Use in Drug Discovery to Evaluate Amyloid-β Lowering Therapeutics
CNS & Neurological Disorders - Drug Targets Deciphering the Physiology Underlying the Rapid Clinical Effects of Perispinal Etanercept in Alzheimers Disease
Current Alzheimer Research Subject Index to Volume 4
Current Drug Targets - Cardiovascular & Hematological Disorders Predicting Drug-Likeness: Why and How ?
Current Topics in Medicinal Chemistry Understanding Crime in Schizophrenia - Risk Factors and Prevention Review
Current Psychiatry Reviews Alzheimers Disease and Retinal Neurodegeneration
Current Alzheimer Research Ex Vivo Gene Therapy and Vision
Current Gene Therapy The NK-1 Receptor: A New Target in Cancer Therapy
Current Drug Targets Methods for Identifying Cardiovascular Agents: A Review
Recent Patents on Cardiovascular Drug Discovery Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)
Current Pharmaceutical Design Effect of Valerian Extract on GABRB3 Gene MRNA Expression and Sedation in BALB/C Mice
Current Bioactive Compounds